1. The degradation behavior of calcium‐rich hydroxyapatite foams in vitro
- Author
-
Jörg C. Gerlach, Qinghao Zhang, Ian Nettleship, Wenfu Wang, Changsheng Liu, and Eva Schmelzer
- Subjects
Materials science ,0206 medical engineering ,Biomedical Engineering ,chemistry.chemical_element ,Biocompatible Materials ,02 engineering and technology ,Calcium ,Endothelial cell differentiation ,Calcium nitrate ,Calcium Carbonate ,Biomaterials ,chemistry.chemical_compound ,Phase (matter) ,Human Umbilical Vein Endothelial Cells ,Humans ,Cells, Cultured ,Nitrates ,Metals and Alloys ,Endothelial Cells ,Biomaterial ,X-Ray Microtomography ,Calcium Compounds ,021001 nanoscience & nanotechnology ,020601 biomedical engineering ,Durapatite ,Calcium carbonate ,Solubility ,chemistry ,Chemical engineering ,Bone Substitutes ,Emulsion ,Ceramics and Composites ,Degradation (geology) ,Emulsions ,0210 nano-technology - Abstract
Hydroxyapatite (HA) is a well-known regenerative biomaterial. However, the slow degradation rate of HA is still an obstacle in clinical applications. In this study, we concentrated on investigating the degradation behavior of the calcium-rich HA foams, which had a demonstrated effect on blood differentiation in previous studies. The HA foams were processed by an emulsion method and were infiltrated with calcium nitrate to create a calcium carbonate second phase, heterogeneously distributed on and under the surface of the foam. During the 28-day solubility test, the calcium carbonate phase contributed to enhanced Ca2+ ion release into the saline compared to phase pure HA foams. Both types of foams were biocompatible as demonstrated by human endothelial cell culture on their surface. The release of calcium ions, the degradation behavior, and the endothelial cell differentiation behavior suggest this biphasic ceramic is a candidate for bone marrow in vitro culture and a possible bone substitute material.
- Published
- 2020
- Full Text
- View/download PDF